Validation of an enzyme-linked immunosorbent assay screening method and a liquid chromatography-tandem mass spectrometry confirmation method for the identification and quantification of ketamine and norketamine in urine samples from Malaysia

Journal of Analytical Toxicology

Volumn 33, Issue 6, 2009, Pages 310-321

  Harun, Norlida ^a   Anderson, Robert A ^a   Miller, Eleanor I ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; KETAMINE; NORKETAMINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CROSS REACTION; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FORENSIC TOXICOLOGY; HUMAN; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MALAYSIA; METABOLITE; SCREENING; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; URINALYSIS; VALIDATION STUDY;

EID: 68849112541     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/33.6.310     Document Type: Article

References (40)

1. H.S. Leong, N.L. Tan, C.P. Lui, and T.K. Lee. Evaluation of ketamine abuse using hair analysis: Concentration trends in Singapore population. J. Anal. Toxicol. 29: 314-318 (2005).
2. A.C. Lua, H.R. Lin, Y.T. Tseng, A.R. Hu, and P.C. Yeh. Profiles of urine samples from participants at rave party in Taiwan: prevalence of ketamine and MDMA abuse. Forensic Sci. Int. 36: 47-51 (2003).
3. K.A. Moore, E.M. Kilbane, and R. Jones. Tissue distribution of ketamine in a mixed drug fatality. J. Forensic Sci. 42(6): 1183-1185 (2007).
4. H.V. Curran and C. Morgan. Cognitive, dissociative and psychogenic effects of ketamine in recreational users on the night of drug use and 3 days later. Addiction 95(4): 575-590 (2000).
5. European Monitoring Centre for Drugs and Drug Addition (EMCDDA). Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs. www.emcdda.europa.eu/attachements.cfm/att-1148-EN-ketami ne-final-riskassessment-report.pdf
6. A.R.W. Jackson and J.M. Jackson. Forensic Science, 2nd ed. Pearson Education, Harlow, U.K., 2008.
7. J.A. Morgan, M. Ricelli, C.H. Maitland, and H.V Curran. Long term effects of ketamine: evidence for a persisting impairment of source memory in recreational users. Drug Alcohol Depend. 75: 301-308 (2004).
8. R.L. Lin and A.C. Lua. Detection of acid-labile conjugates of ketamine and its metabolites in urine samples collected from pub participants. J. Anal. Toxicol. 28: 181-186 (2004).
9. A. Negrusz, P. Adamowicz, and B.K. Saini. Detection of ketamine and norketamine in urine of nonhuman primates after a single dose of ketamine using microplate enzyme-linked immunosorbent assay (ELISA) and NCI-GC-MS. J. Anal. Toxicol. 29: 163-168 (2005).
10. M.E.C. Tan, H.Y. Moy, L.C.P. Moy, and T.K. Lee. Evaluation of an ELISA test kit in the screening of ketamine in urine. Forensic Sci. Int. 136(suppl 1): 305 (2003).
11. S.L.Chou, M.H. Yang, Y.C. Ling, and Y.S. Giang. Gas chromatography- isotope dilution mass spectrometry preceded by liquid- liquid extraction and chemical derivatization for the determination of ketamine and norketamine in urine. J. Chromatogr. B 79: 937-950 (2004)
12. M.K. Huang, C. Liu, J.H. Li, and S.D. Huang. Quantitative detection of ketamine, norketamine and dehydronorketamine in urine using chemical derivatization followed by gas chromatography- mass spectrometry. J. Chromatogr. B 820: 165-173 (2005).
13. E.M. Kim, J.S. Lee, S.K. Choi, M.A. Lim, and H.S. Chung. Analysis of ketamine and norketamine in urine by automatic solidphase extraction (SPE) and positive ion chemical ionization-gas chromatography-mass spectrometry. (PCI-GC-MS). Forensic Sci. Int. 174: 197-202 (2008).
14. C.H. Wu, M.H. Huang, S.M. Wang, C.C. Lin, and R.H. Liu. Gas chromatography-mass spectrometry analysis of ketamine and its metabolites-a comparative study on the utilization of different derivatization groups. J. Chromatogr. A 1157: 336-351 (2007).
15. P.S. Cheng, C.Y. Fu, C.H. Lee, C. Liu, and C.S. Chien. GC-MS quantification of ketamine, norketamine, and dehydronorketamine in urine specimens and comparative study using ELISA as the preliminary test methodology. J. Chromatogr. B 852: 443-449 (2007).
16. P. Xiang, M. Shen, and X. Zhuo. Hair analysis for ketamine and its metabolites. Forensic Sci. Int. 162: 131-134 (2006).
17. K.A. Moore, J. Sklerov, B. Levine, and A.J. Jacobs. Urine concentrations of ketamine and norketamine following illegal consumption. J. Anal. Toxicol. 25: 583-588 (2001).
18. J.Y.K Cheng and V.K.K. Mok. Rapid determination of ketamine in urine by liquid chromatography-tandem mass spectrometry for a high throughput laboratory. Forensic Sci. Int. 142: 9-15 (2004).
19. A.C. Lua and H.R. Lin. A rapid and sensitive ESI-MS screening procedure for ketamine and norketamine in urine samples. J. Anal. Toxicol. 28: 680-684 (2004).
20. M.H. Huang, M.Y. Wu, C.H. Wu, J.L. Tsai, H.H. Lee, and R.H. Liu. Performance characteristics of ELISA for monitoring ketamine exposure. Clin. Chim. Acta 379: 59-65 (2007).
21. P. Adamowicz and M. Kala. Urinary excretion rates of ketamine and norketamine following therapeutic ketamine administration: method and detection window considerations. J. Anal. Toxicol. 28: 376-382 (2004).
22. Y. Hijazi and R. Bolieu. Contribution of CYP3A4, CYP2B6 and CYP2C9 isoforms to N-methylation of ketamine in human liver microsomes. Drug Metab. Dispos. 30: 853-858 (2002).
23. R.C. Baselt. Disposition of Toxic Drugs and Chemicals in Man, 6th ed. Biomedical Publications, Foster City, CA, 2002.
24. T.M. Pizzolato, M.J. Lopez de Alda, and D. Barceló. LC-based analysis of drugs of abuse and their metabolites in urine. Trends Anal. Chem. 26: 609-621 (2007).
25. M.C. Parkin, S.C. Turfus, N.W. Smith, J.M. Halket, R.A. Braithwaite, S.P. Elliott, M.D. Osselton, and D.A. Cowan. Detection of ketamine and its metabolites in urine by ultra high pressure liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 876: 137-142 (2008).
26. A.E. Elian. ELISA detection of clonazepam and 7-aminoclonazepam in whole blood and urine. Forensic Sci. Int. 134: 54-56 (2003).
27. http://www.rmp.gov.my/statistics/statistic-content.cfm?tajuk=13 &title=Narkotik%20-%20Rampasan
28. A.I. Al-Asmari and R.A. Anderson. Quantification of opioids and their metabolites in autopsy blood by liquid chromatography- tandem mass spectrometry. J. Anal. Toxicol. 31: 394-408 (2007).
29. M.M. Ariffin and R.A. Anderson. LC-MS/MS analysis of quaternary ammonium drugs and herbicides in whole blood. J. Chromatogr. B 842: 91-97 (2006).
30. K. Lachenmeier, F. Musshoff, and B. Madea. Determination of opiates and cocaine in hair using automated enzyme immunoassay screening methodologies followed by gas chromatographic- mass spectrometric (GC-MS) confirmation. Forensic Sci. Int. 159: 189-199 (2006).
31. E.I. Miller, H.J. Torrance, and J.S. Oliver. Validation of the Immunalysis ® microplate ELISA for the detection of buprenorphine and its metabolite norbuprenorphine in urine. J. Anal. Toxicol. 30: 115-119 (2006).
32. M. Laloup, G. Tilman, V. Maes, G. De Boeck, P. Wallemacq, J. Ramaekers, and N. Samyn. Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid. Forensic Sci. Int. 153: 29-37 (2005).
33. E.I. Miller, F.M. Wylie, and J.S. Oliver. Detection of benzodiazepines in hair using ELISA and LC-ESI-MS-MS. J. Anal. Toxicol. 30: 441-448 (2006).
34. http://www.soft-tox.org/docs/Guidelines%202006%20Final.pdf.
35. E. Chambers, D.M. Wagrowski, Z. Lu, and J.R. Mazzeo. Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. J. Chromatogr. B 852: 22-34 (2007).
36. J. Wieber, R. Gugler, J.H. Hengstmann, and H.J. Dengler. Pharmacokinetics of ketamine in man. Anaesthesia 24: 260-263 (1975).
37. R. Kronstrand, T.G. Selden, and M. Josefsson. Analysis of buprenorphine, norbuprenorphine and their glucoronides in urine by LC-MS. J. Anal. Toxicol. 27: 464-469 (2003).
38. X.H. Chen, J.P. Franke, J. Wijsbeek, and R.A. de Zeeuw. Study of lot-to-lot reproducibilities of Bond Elut Certify and Clean Screen DAU mixed-mode solid-phase extraction columns in the extraction of drugs from whole blood. J. Chromatogr. Biomed. Appl. 617: 147-151 (1993).
39. X.H. Chen, J.P. Franke, K. Ensing, J.Wijsbeek, and R.A. de Zeeuw. Semi-automated solid-phase extraction procedure for drug screening in biological fluids using the ASPEC system in combination with Clean Screen DAU columns. J. Chromatogr. Biomed. Appl. 613: 289-294 (1993).
40. United States Department of Justice. Ketamine. Intelligence Bulletin. http://www.usdoj.gov/ndic/pubs10/10255/10255p.pdf.